CyBio AG with Stable Results after Six Months Despite Decline in Revenueread on  

Annual General Meeting 2012: Sales of EUR 11.0 million to EUR 11.5 million forecasted. Operating earnings between EUR 1.0 million and EUR 1.2 million expected.read on  

Majority Shareholder Establishes Cash Compensation for Delisting at EUR 1.50read on